Estimated Diabetes In Japan Grows To One Per Every 5.6 Adults
This article was originally published in PharmAsia News
Executive Summary
According to a National Health and Diet Survey of 2006 conducted by Japan's Ministry of Heath, Labor and Welfare, released on April 30, the total number of diabetes patients and candidates is estimated to be 18.7 million, an increase of 15.4 percent or 2.5 million since 2002. MHLW sites a rapidly aging population, lack of exercise and high calorie diets as reasons. The estimate is based on a survey conducted in 3,600 families and utilizing blood samples of 4,296 adults. (Click here for more - Japanese language
You may also be interested in...
AstraZeneca, BMS Expand Development Of Diabetes Drug Dapagliflozin To Include Japan
TOKYO - AstraZeneca K.K., a fully owned Japanese subsidiary of AstraZeneca, has announced plans to market type 2 diabetes treatment dapagliflozin jointly with Bristol-Meyers Squibb in Japan, a company spokesman said
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.